The myocardial infarction (MI) therapeutics market will register a CAGR of almost 3% by 2023

Tuesday, February 12, 2019 Heart Disease News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Feb. 11, 2019 /PRNewswire/ -- About this marketMI along with other cardiovascular problems, is the leading

cause of premature deaths in the world. The rising incidence of coronary artery disease, obesity, diabetes, and hypertension, along with a sedentary lifestyle, smoking, and reduced physical activities, is expected to increase the risk factors for cardiovascular
diseases including MI. Apart from these factors, the rapid rise in the geriatric population is increasing the incidence of MI. Hence, the incidence of MI is expected to increase with the rapidly expanding geriatric population. The rising incidence of MI will propel the growth of the market during the forecast period. Technavio's analysts have predicted that the myocardial infarction (MI) therapeutics market will register a CAGR of almost 3% by 2023.Download the full report: https://www.reportbuyer.com/product/5734241 Market OverviewIncreased adoption of novel antithromboticsNovel antithrombotics such as NOACs and antiplatelet drugs (BRILINTA and Effient) possess the potential to expand the scope of the treatment for MI. These drugs offer significant advantages such as target specificity. The market also contains specific antidotes for these drugs. which can help prevent life-threatening or uncontrolled bleeding.Extensive use of genericsA generic drug is a medication that is the same as the existing approved branded drug in terms of dosage form, safety, strength, route of administration, quality, and performance characteristics. Generic drugs are allowed for sale after the expiry of the patent of the original branded drug. Thus, generic drugs have comparatively lower prices than the branded drugs.For the detailed list of factors that will drive and challenge the growth of the myocardial infarction (MI) therapeutics market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be moderately concentrated and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Download the full report: https://www.reportbuyer.com/product/5734241 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-myocardial-infarction-mi-therapeutics-market-will-register-a-cagr-of-almost-3-by-2023-300793085.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store